Cargando…

Bone Complications Among Prostate Cancer Survivors: Long-Term Follow-Up From the Prostate Cancer Outcomes Study

BACKGROUND: To assess the relationship between ADT exposure and self-reported bone complications among men in a population-based cohort of prostate cancer survivors followed for 15 years after diagnosis. METHODS: The Prostate Cancer Outcomes Study (PCOS) enrolled 3,533 patients diagnosed with prosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgans, Alicia K., Fan, Kang-Hsien, Koyama, Tatsuki, Albertsen, Peter C., Goodman, Michael, Hamilton, Ann S., Hoffman, Richard M., Stanford, Janet L., Stroup, Antoinette M., Penson, David F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227957/ https://www.ncbi.nlm.nih.gov/pubmed/25134939 http://dx.doi.org/10.1038/pcan.2014.31

Ejemplares similares

Successful external validation of a model to predict other cause mortality in localized prostate cancer
por: Kent, Matthew, et al.
Publicado: (2016)

Association between body mass index and localized prostate cancer management and disease‐specific quality of life
por: Samora, Nathan L., et al.
Publicado: (2022)

The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer
por: Joyce, Daniel D, et al.
Publicado: (2022)

Osteoclast inhibitor treatment among men with metastatic castration-resistant prostate cancer
por: Sonnenburg, Daniel, et al.
Publicado: (2018)

Patient expectations of benefit from systemic treatments for metastatic prostate cancer
por: Oswald, Laura B., et al.
Publicado: (2019)

Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy
por: Ryan, Charles J., et al.
Publicado: (2020)

A review of prostate cancer treatment impact on the CNS and cognitive function
por: Ryan, Charles, et al.
Publicado: (2019)

What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study
por: Oswald, Laura B, et al.
Publicado: (2020)

Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019)

Optimal assessment of quality of life for patients with prostate cancer
por: Briggs, Logan G, et al.
Publicado: (2022)

Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams
por: Shore, Neal D., et al.
Publicado: (2022)

Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
por: Love, Harold D., et al.
Publicado: (2009)

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer
por: Beer, Tomasz M., et al.
Publicado: (2022)

How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope
por: Narayan, Vivek, et al.
Publicado: (2021)

Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews
por: Leaning, Darren, et al.
Publicado: (2023)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Risk of second cancer among young prostate cancer survivors
por: Zhang, Hong, et al.
Publicado: (2021)

Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes
por: Hudson, Shawna V, et al.
Publicado: (2015)

Benefit finding in long-term prostate cancer survivors
por: Lassmann, Irène, et al.
Publicado: (2021)

Telehealth use and perceptions among prostate cancer survivors
por: Chen, Luke W., et al.
Publicado: (2023)

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors
por: Wefel, Jeffrey S., et al.
Publicado: (2022)

Obesity, body composition, and prostate cancer
por: Fowke, Jay H, et al.
Publicado: (2012)

Disparities in colorectal cancer screening among breast and prostate cancer survivors
por: Dash, Chiranjeev, et al.
Publicado: (2021)

Robotic-Assisted Laparoscopic Prostatectomy for High-Risk Prostate Cancer: Technical Considerations and Review of the Literature
por: Stroup, Sean P., et al.
Publicado: (2011)

Cardiovascular Complications of Prostate Cancer Treatment
por: Wilk, Michał, et al.
Publicado: (2020)

Medical Help-Seeking for Sexual Concerns in Prostate Cancer Survivors
por: Hyde, Melissa K., et al.
Publicado: (2016)

Pain, fatigue and depression symptom cluster in survivors of prostate cancer
por: Baden, Manisha, et al.
Publicado: (2020)

Wait and Hurry Up: Radiation Therapy for Prostate Cancer During the COVID-19 Pandemic
por: Hoffman, Karen E.
Publicado: (2020)

Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads
por: Schumacher, Frank A, et al.
Publicado: (2022)

Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression
por: Stabler, Sally, et al.
Publicado: (2011)

Measures of mortality in prostatic cancer.
por: Goodman, C. M., et al.
Publicado: (1990)

Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia
por: Saito, Shigeyoshi, et al.
Publicado: (2022)

Increased risk of high-grade prostate cancer among testicular cancer survivors
por: Zhang, Hong, et al.
Publicado: (2022)

Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting
por: Freedland, Stephen J., et al.
Publicado: (2022)

Replication of a Genetic Variant for Prostate Cancer-Specific Mortality
por: Penney, Kathryn L., et al.
Publicado: (2015)

Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer
por: Wang, Dian, et al.
Publicado: (2014)

Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms
por: Fowke, Jay H., et al.
Publicado: (2016)

Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
por: Wright, Jonathan L., et al.
Publicado: (2009)

Development and evaluation of a support program for prostate cancer survivors in Alaska
por: Kelley, Stacy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vnt3862esqbg7g8v7pejr0428t